Real Hope For Cancer Patients | Precision Biologics

UNIQUE DISCOVERY PLATFORM

realize our potential

LEARN MORE

We have a platform of patient tumor
derived anticancer vaccines.

THERAPEUTICS

leaders in biotherapeutics

LEARN MORE

Our unique platform, combined with breakthroughs in biotechnology, enable us to produce targeted antibodies that weren’t possible just a few years ago.

COMPANION DIAGNOSTICS

explore our program

LEARN MORE

Our monoclonal antibodies are designed to target the tumor without harming healthy cells.

Precision Biologics is dedicated to improving the lives of cancer patients through its innovative therapeutic and diagnostic products.

Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026

DATE: March 2, 2026

Dr. Philip M Arlen to present Keynote at the 6th Ace Drug Discovery Summit, London, UK, February 19, 2026

DATE: February 17, 2026

Precision Biologics to Reveal Preclinical Efficacy of Novel Tumor-Specific ADC against multiple human cancer types at SITC 2025

DATE: November 5, 2025

Precision Biologics to Unveil In Vitro and In Vivo Efficacy of New ADC against human ovarian cancer at AACR Special Conference

DATE: September 19, 2025

Precision Biologics to present data on new antibody-drug conjugate PB-223 ADC at AACR, Chicago, IL, April 25 - 30, 2025

DATE: April 25, 2025

Dr. Philip M Arlen to present at Festival of Biologics USA, San Diego, CA, April 23 - 24, 2025

DATE: April 18, 2025

# of people living with cancer in the US

annual # of new cases of cancer in the US

annual # of deaths from cancer in the US

*Source: seer.cancer.gov/statfacts (2024)

Discover our innovative Leaders.

Meet our Team

Officer, Board Member

Philip Arlen

President and CEO

Officer

Al Tsang

Chief Scientific Officer

Officer

Sharon A. Mavroukakis

RN, MS

Officer

Massimo Fantini

Director R & D

News and Events

Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026

Precision Biologics, Inc. CEO Philip M. Arlen, MD, will give a presentation on monoclonal antibodies...

Dr. Philip M Arlen to present Keynote at the 6th Ace Drug Discovery Summit, London, UK, February 19, 2026

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a Keynote speech and present...

Precision Biologics to Reveal Preclinical Efficacy of Novel Tumor-Specific ADC against multiple human cancer types at SITC 2025

BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ -- Precision Biologics, Inc. announces in vitro and in vivo efficacy of its novel...

Home